(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SERONORM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SERONORM

ST13

US500000079222493

Class

1, 5

Filing

79222493

Registration

5567760

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

02/27/2026

Trademark type

Word

Nice classes

1, 5

Filing date

09/05/2017

Registration date

09/25/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/24/2025

Last transaction

02/27/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Billingstad, NO

Examiner

ESTRADA, LINDA M

Current location

Historical data usage

Holders and representatives

Holders

S. A. (pessoa física)
S. A. (pessoa física)

Representatives

Kiranjit K Dharsan Seiter IP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemical and biological preparationsreagents and chemical substances for scientific and research use and laboratory analysisfor control of in vitro diagnostic (IVD) analysis resultsother than for medical or veterinary purposes; chemicalbiochemical and biological preparations for scientific and research use and laboratory analysisfor control of calibration of in vitro diagnostic (IVD) analysis instrumentsother than for medicalpharmaceutical or veterinary use; the before-mentioned goods excluding botanical extracts for use in the preparation of pharmaceutical productscosmetics and foodstuffexcluding pharmaceutical preparations for use in the treatment of infertility and/or ovulation inductionimmunologypediatrics and endocrinologyauto immune diseasesgrowth and metabolismdiseases of the central nervous systemcancerviral diseasesinflammatory disorders

Class 5

Medical diagnostic preparations used to control the results of medical analysisblood teststhat laboratories perform in order to diagnose and treat patients; the before-mentioned goods excluding pharmaceutical preparations for use in the treatment of infertility and/or ovulation inductionimmunologypediatrics and endocrinologyauto immune diseasesgrowth and metabolismdiseases of the central nervous systemcancerviral diseasesinflammatory disorders

Publications

History of USPTO decisions and trademark events.

41 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/26/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/15/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

02/15/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/15/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/15/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/24/2025

71AG

REGISTERED-SEC.71 ACCEPTED

02/24/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/24/2025

ES71

TEAS SECTION 71 RECEIVED

09/18/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/27/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/25/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/07/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/05/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/02/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/13/2019

FIMP

FINAL DISPOSITION PROCESSED

01/13/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/25/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

09/25/2018

GPNX

NOTIFICATION PROCESSED BY IB

07/20/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/10/2018

PUBO

PUBLISHED FOR OPPOSITION

07/10/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/04/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/04/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/20/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/07/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

06/06/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/06/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

06/06/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/06/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/14/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/14/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/14/2018

RFNT

REFUSAL PROCESSED BY IB

01/19/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/29/2017

RFRR

REFUSAL PROCESSED BY MPU

12/28/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/14/2017

CNRT

NON-FINAL ACTION WRITTEN

12/13/2017

MAFR

APPLICATION FILING RECEIPT MAILED

12/12/2017

DOCK

ASSIGNED TO EXAMINER

12/08/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/08/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/07/2017

Continuous trademark protection

Get notified about every new filing that threatens SERONORM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.